New shot could tame tough eczema
NCT ID NCT06397911
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests a drug called FB825 in adults with moderate-to-severe atopic dermatitis (eczema). Participants receive five injections over 12 weeks, either FB825 or a placebo, to see if it improves skin symptoms like redness and itching. The goal is to find a new treatment option for people whose eczema is hard to control.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- FB825 (a drug given as injections under the skin)
- What this could lead to
- If it works, this could point toward a new treatment option for people with moderate-to-severe eczema that is not well controlled by current therapies.
- What could go wrong
- This is an early Phase 2 trial with only 114 participants, so results may not apply to everyone. The drug may not work better than placebo, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
California Allergy and Asthma Medical Group
RECRUITINGLos Angeles, California, 90025, United States
-
Center for Clinical Studies
RECRUITINGWebster, Texas, 77598, United States
-
Center for Dermatology Clinical Research, Inc.
RECRUITINGFremont, California, 94538, United States
-
China Medical University Hospital
RECRUITINGTaichung, Taiwan
-
First OC Dermatology
RECRUITINGFountain Valley, California, 92708, United States
-
Kaohsiung Chang Gung Memorial Hospital
RECRUITINGKaohsiung City, Taiwan
-
Kaohsiung Veterans General Hospital
RECRUITINGKaohsiung City, Taiwan
-
Linkou Chang Gung Memorial Hospital
RECRUITINGNew Taipei City, Taiwan
-
National Cheng Kung University Hospital
RECRUITINGTainan, Taiwan
-
National Taiwan University Hospital
RECRUITINGTaipei, Taiwan
-
Taipei Mackay Memorial Hospital
RECRUITINGTaipei, Taiwan
-
Taipei Medical University-Shuang Ho Hospital
RECRUITINGNew Taipei City, Taiwan
-
Taipei Veterans General Hospital
RECRUITINGTaipei, Taiwan
-
Tri-Service General Hospital
RECRUITINGTaipei, Taiwan
-
UT Health Science Houston
RECRUITINGBellaire, Texas, 77401, United States
-
University of California, Davis Health, Department of Dermatology
RECRUITINGSacramento, California, 95816, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection calm severe eczema when creams fall short?
- Can a new biologic calm severe eczema?
- Can a daily probiotic soothe colicky babies and calm eczema?
- Can a new injection match an existing eczema treatment?
- Can Real-World data unlock better skin disease care?
- Can a meditation app soothe teen eczema?